Completed Transactions

Completed Transactions > Healthcare & Life Sciences > Catachem Acquired By Private Investor

Catachem Acquired By Private Investor



Feb 2023



We are pleased to share the sale of our client, Catachem, Inc., to a Private Investor. The deal closed February 28, 2023.

Catachem, Inc., located in Oxford, Connecticut, is a leading U.S.-based manufacturer of clinical chemistry reagents for use on automated analyzers for both veterinary and human diagnostic labs. The Company’s reagents offer strong performance in terms of accuracy, precision, stability and cost.

Generational Equity Executive Managing Director, M&A-Technology Practice Leader, David Fergusson, and his team, led by Senior M&A Advisor, Ray Palombi, with the support of Managing Director, M&A, Corey Painter, successfully closed the transaction. Executive Managing Director Bill Kushnir established the initial relationship with Catachem.

‘’Catachem is an innovative company with a long history as an industry leader. We were able to find the right buyer, with an experienced management team, to carry the company forward,” said Palombi.

If you would like to explore other transactions our associates have supported in this industry, visit our dedicated Healthcare & Life Sciences M&A Deals page.